Precise modeling of dry surface biofilms in hospitals is critical for understanding their role in hospital-acquired infection transmission and surface contamination. Using a representative culture condition which includes a nutrient source is key to developing a phenotypically accurate biofilm community. This will enable accurate laboratory testing of cleaning products and their efficacy against dry surface biofilms.
Microbial biofilms are a major hindrance in the wound healing process, prolonging the inflammatory response phase, thus making them a target in treatment. The aim of this study is to assess the antibacterial properties of commercially available wound dressings, of various material composition and antibacterial agents, towards multiple in vitro microbial and biofilm models. A variety of in vitro microbial and biofilm models were utilised to evaluate the ability of wound dressing materials to sequester microbes, prevent dissemination and manage bioburden. Sequestering and dissemination models were used to evaluate the ability of wound dressing materials to prevent the biofilm‐forming bacterium, Pseudomonas aeruginosa, from migrating through dressing materials over a 24–72 h challenge period. Additionally, Centre for Disease Control (CDC) Bioreactor and Drip Flow models were used to evaluate antibacterial killing efficacy towards established P. aeruginosa and Staphylococcus aureus biofilms using more challenging, wound‐like models. Controlled‐release iodine foam and silver‐impregnated carboxymethylcellulose (CMC) wound dressing materials demonstrated potent biofilm management properties in comparison to a methylene blue and gentian violet‐containing foam dressing. Both the iodine‐containing foam and silver‐impregnated CMC materials effectively prevented viable P. aeruginosa dissemination for up to 72 h. In addition, the controlled‐release iodine foam and silver‐impregnated CMC materials reduced P. aeruginosa bioburden in the Drip Flow model. The controlled‐release iodine foam demonstrated superiority in the CDC Bioreactor model, as both the silver‐ and iodine‐containing materials reduced S. aureus to the limit of detection, but P. aeruginosa growth was only completely reduced by controlled‐release iodine foam dressing materials. The data generated within the in vitro biofilm models supports the clinical data available in the public domain for the implementation of iodine foam dressings for effective biofilm management and control in wound care.
Background: Surgical site infections (SSIs) have been shown to increase patient morbidity and mortality, impact on quality of life and place a significant economic burden on healthcare systems worldwide. Irrigation using wound cleansing and antiseptic effective solutions during surgical procedures is a key part of SSI prevention. The optimal solution would have minimal cytotoxicity to the patient while maintaining a minimum concentration required for antimicrobial activity necessary to prevent opportunistic pathogens and biofilm formation. Method: A variety of common wound irrigation products, including polyhexanide in various concentrations and compositions, iodine and hypochlorous acid-based solutions, were tested and compared for their activity against pathogens according to the ESKAPE group of nosocomial relevant microbes. The antimicrobial efficacy of the solutions was tested against planktonic cells using a time-kill assay. Its minimal bactericidal concentration (MBC) and its cytotoxicity against mouse fibroblast cells were determined. Finally, the Therapeutic Index (TI) was compared and the biofilm activity of a selected solution containing 0.1% polyhexanide (PHMB) was tested. Results: Irrigation solutions containing 0.1% PHMB demonstrated rapid inactivation against planktonic cultures, achieving >4 lg reduction within 60 seconds. When comparing the TI of all irrigation solutions tested, the combination of 0.1% PHMB and poloxamer as an additive showed the best results in killing nosocomial pathogens and also to be less cytotoxic to mammalian fibroblasts, as demonstrated for PREVENTIA (R) Surgical Irrigation. When exposed to five single-species biofilms, PREVENTIA (R) Surgical Irrigation showed a 3 lg reduction (average) after 60 minutes; this was supported by microscopy showing significant biofilm disruption and an abundance of non-viable microcolony formations. Conclusion: This study highlights the impact of irrigation solutions containing PHMB. It also demonstrated the effect of using different concentrations of PHMB in combination with surfactants as additives. The combination of 0.1% PHMB and poloxamer as a surfactant demonstrated effective benefits in eradicating established biofilm combined with a relatively high Therapeutic Index (TI), indicating low cytotoxicity and high bactericidal activity.
Studies on the epidemiology of dry-surface biofilms (DSBs) within healthcare settings have shown an almost universal distribution across frequently touched items. Despite a growing body of evidence for DSBs in hospitals, little attention has been paid to the recovery capacity of techniques used to detect these microbial communities. Biofilms are inherently difficult to remove from surfaces due to adhesive substances within their matrix and may act as sources of infection, but to what extent is largely unknown. In this study, we evaluate the recovery efficiencies of commonly used environmental swabs against DSBs containing 7.24 log10 Acinetobacter baumannii cm−2, using a drip flow reactor and desiccation cycle. Biofilm presence was visually confirmed using episcopic differential interference contrast microscopy combined with epifluorescence and quantified using sonicated viable plate counts. The swab materials used comprised foam, viscose and cotton, all of which were pre-moistened using a buffer solution. The surfaces were vigorously swabbed by each material type and the resultant microbe populations for both swabs and remaining DSBs were quantified. Our results found foam-tipped swabs to be superior, detecting on average 30 % of the original DSB contamination; followed by viscose (6 %) and cotton (3 %). However, no distinct difference was revealed in the concentration of microbes remaining on the surface after swabbing for each swab type, suggesting there is variation in the capacity for each swab to release biofilm-associated micro-organisms. We conclude whilst environmental swabs do possess the ability to detect biofilms on dry surfaces, the reduced efficiencies are likely to cause an underestimation of the microbes present and should be considered during clinical application.
Chronic wounds are a significant burden on patients and hospitals globally, with all exhibiting high microbial loading and biofilm. Wound cleansing is critical for removing foreign contaminants, damaged tissue and opportunistic pathogens, allowing for improved healing. This study addresses the need for a standardised in vitro preclinical model for comparing the efficacy of antimicrobial wound cleansing solutions with mechanical disruption on biofilms. A novel model was developed to emulate cleaning practises whilst standardising pressure applied and scrubbing forces applied to the wound bed. Using wounded porcine explants, microbial biofilms were formed on the surface before exposure to varying physical parameters and cleaning solutions. The results showed that both increased pressure and scrubbing duration had a positive impact on biofilm removal, demonstrating > 1 log reduction in microbial levels. The model was able to show the significant difference in cleaning solutions between saline and an antimicrobial‐based solution (HClO), > 4.5 log reduction, whilst under identical conditions. Confocal laser microscopy, using fluorescent viability stains, provided supporting evidence of biofilm disruption using gauze. The model's adaptability and versatility help to provide clinically relevant in vitro evidence and effective comparisons of wound cleansing agents on biofilms through the standardisation of different cleaning techniques.
Eschar and slough in wounds serve as a reservoir for microorganisms and biofilms, damaged/devitalised cells, and inflammatory chemokines/cytokines, which work to initiate and prolong persistent inflammation and increase the risk of infection. Biofilm-related inflammation and infections are considered to be highly prevalent in acute wounds and chronic wounds. As slough is known to harbour biofilms, measuring the efficacy of antimicrobials in killing microbes both within and under slough is warranted. This highlights the need for more clinically relevant wound biofilm models to address this significant clinical need. Consequently, in this study, we developed an in vitro artificial wound slough (AWS) biofilm model produced by forming a biofilm below a layer of AWS, the latter of which was composed of the main protein components reported in wound eschar and slough, namely collagen, elastin, and fibrin. The model was employed to investigate the antibiofilm and antibacterial efficacy of a new patented smart next-generation antibiofilm technology composed of silver–zinc EDTA complexes and designed as a family of multifunctional metal complexes referred to as MMCs, in a liquid format, and to determine both the performance and penetration through AWS to control and manage biofilms. The results demonstrated the ability of the AWS–biofilm model to be employed for the evaluation of the efficacy of a new antibiofilm and antimicrobial next-generation smart technology. The results also demonstrated the potential for the proprietary EDTA multifunctional metal complexes to be used for the disruption of biofilms, such as those that form in chronic wounds.